Overview: Chlamydia Trachomatis PCR TestIntroduction: The Chlamydia Trachomatis PCR Test detects Chlamydia trachomatis DNA, confirming active infection causing pelvic pain or infertility. Aligned with 2023 IDSA guidelines, it uses PCR for high specificity, aiding in infectious disease screening. This test is critical for guiding diagnosis, treatment, and improving outcomes in virology for patients with suspected Chlamydia infection.
Other Names: Chlamydia PCR Assay, Chlamydia Detection Test.
FDA Status: Laboratory-developed test (LDT), meeting virology standards for diagnostic accuracy.
Historical Milestone: Chlamydia PCR testing began in the 1990s with molecular diagnostics. Real-time PCR emerged in the 2000s, improving detection accuracy.
Purpose: Diagnoses active Chlamydia trachomatis infection, guides treatment, and monitors bacterial presence in patients with pelvic pain or infertility.
Test Parameters: 1. Chlamydia Trachomatis DNA
Pretest Condition: No fasting required. Collect swab, urine, cervical swab, urethral swab, or saliva at any time. Report symptoms like pelvic pain or infertility, and list recent antibiotic use.
Specimen: 1-2 swabs (sterile swab/transport medium), 5-20 mL urine (sterile container), 1-2 cervical swabs (sterile swab/transport medium), 1-2 urethral swabs (sterile swab/transport medium), or 1-2 mL saliva (sterile container). Transport in a biohazard bag within 24 hours.
Sample Stability at Room Temperature: 24 hours
Sample Stability at Refrigeration: 48 hours
Sample Stability at Frozen: Not frozen
Medical History: Document pelvic pain, infertility, or sexual history. Include current medications, especially antibiotics.
Consent: Written consent required, detailing the tests purpose, diagnostic implications, and potential need for antibiotic therapy.
Procedural Considerations: Uses PCR to detect Chlamydia trachomatis DNA. Results are available in 3-5 days, supporting clinical decisions.
Factors Affecting Result Accuracy: Improper storage or delayed transport can degrade DNA. Recent antibiotics may reduce sensitivity.
Clinical Significance: Positive results confirm active Chlamydia infection, prompting antibiotic therapy. Negative results may require repeat testing.
Specialist Consultation: Consult an infectious disease specialist for result interpretation. A gynecologist referral is advised for infertility cases.
Additional Supporting Tests: Chlamydia IgG/IgM tests, culture, or pelvic ultrasound to confirm infection or assess complications.
Test Limitations: False negatives may occur with low bacterial loads. Results require clinical correlation with history.
References: IDSA Chlamydia Guidelines, 2023; Clinical Infectious Diseases, Workowski KA, 2022.
